Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mindray ultrasound, analyzer gain 510(k)s

This article was originally published in The Gray Sheet

Executive Summary

Shenzhen, China-based patient monitoring, life support, in-vitro diagnostic and medical imaging firm announces March 31 the U.S. and international availability of its portable M5 ultrasound imaging system and BS-200 automatic bio-chemistry analyzer. The six-kilogram M5 is the company's first laptop-size ultrasound imaging device. BS-200 is an automatic, low-throughput bio-chemistry analyzer designed to replace semi-automatic analyzers, and is targeted to rural hospitals and labs in China and other international markets. Mindray also submitted late last year for FDA sign-off for three BeneView multi-parameter patient monitoring devices, and it expects Chinese approval by July for its EX55 and EX65 compact anesthesia machines

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel